US SB2895 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on November 19 2019 - 25% progression, died in committee
Action: 2019-11-19 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 19 2019 - 25% progression, died in committee
Action: 2019-11-19 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Controlled Substances Act to more effectively regulate selective androgen receptor modulators, and for other purposes.
Title
SARMs Control Act of 2019 Selective Androgen Receptor Modulators Control Act of 2019
Sponsors
Sen. Chuck Grassley [R-IA] | Sen. Sheldon Whitehouse [D-RI] |
History
Date | Chamber | Action |
---|---|---|
2019-11-19 | Senate | Read twice and referred to the Committee on the Judiciary. |
Subjects
Crime and law enforcement
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Food supply, safety, and labeling
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Food supply, safety, and labeling
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/2895/all-info |
Text | https://www.congress.gov/116/bills/s2895/BILLS-116s2895is.pdf |